ID   EPHA6_HUMAN             Reviewed;        1036 AA.
AC   Q9UF33; D6RAL5;
DT   16-MAY-2006, integrated into UniProtKB/Swiss-Prot.
DT   14-MAY-2014, sequence version 3.
DT   12-OCT-2022, entry version 176.
DE   RecName: Full=Ephrin type-A receptor 6;
DE            EC=2.7.10.1;
DE   AltName: Full=EPH homology kinase 2;
DE            Short=EHK-2;
DE   AltName: Full=EPH-like kinase 12;
DE            Short=EK12;
DE   Flags: Precursor;
GN   Name=EPHA6; Synonyms=EHK2, HEK12;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Testis;
RX   PubMed=17974005; DOI=10.1186/1471-2164-8-399;
RA   Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,
RA   Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H., Heubner D.,
RA   Hoerlein A., Michel G., Wedler H., Koehrer K., Ottenwaelder B., Poustka A.,
RA   Wiemann S., Schupp I.;
RT   "The full-ORF clone resource of the German cDNA consortium.";
RL   BMC Genomics 8:399-399(2007).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16641997; DOI=10.1038/nature04728;
RA   Muzny D.M., Scherer S.E., Kaul R., Wang J., Yu J., Sudbrak R., Buhay C.J.,
RA   Chen R., Cree A., Ding Y., Dugan-Rocha S., Gill R., Gunaratne P.,
RA   Harris R.A., Hawes A.C., Hernandez J., Hodgson A.V., Hume J., Jackson A.,
RA   Khan Z.M., Kovar-Smith C., Lewis L.R., Lozado R.J., Metzker M.L.,
RA   Milosavljevic A., Miner G.R., Morgan M.B., Nazareth L.V., Scott G.,
RA   Sodergren E., Song X.-Z., Steffen D., Wei S., Wheeler D.A., Wright M.W.,
RA   Worley K.C., Yuan Y., Zhang Z., Adams C.Q., Ansari-Lari M.A., Ayele M.,
RA   Brown M.J., Chen G., Chen Z., Clendenning J., Clerc-Blankenburg K.P.,
RA   Chen R., Chen Z., Davis C., Delgado O., Dinh H.H., Dong W., Draper H.,
RA   Ernst S., Fu G., Gonzalez-Garay M.L., Garcia D.K., Gillett W., Gu J.,
RA   Hao B., Haugen E., Havlak P., He X., Hennig S., Hu S., Huang W.,
RA   Jackson L.R., Jacob L.S., Kelly S.H., Kube M., Levy R., Li Z., Liu B.,
RA   Liu J., Liu W., Lu J., Maheshwari M., Nguyen B.-V., Okwuonu G.O.,
RA   Palmeiri A., Pasternak S., Perez L.M., Phelps K.A., Plopper F.J., Qiang B.,
RA   Raymond C., Rodriguez R., Saenphimmachak C., Santibanez J., Shen H.,
RA   Shen Y., Subramanian S., Tabor P.E., Verduzco D., Waldron L., Wang J.,
RA   Wang J., Wang Q., Williams G.A., Wong G.K.-S., Yao Z., Zhang J., Zhang X.,
RA   Zhao G., Zhou J., Zhou Y., Nelson D., Lehrach H., Reinhardt R.,
RA   Naylor S.L., Yang H., Olson M., Weinstock G., Gibbs R.A.;
RT   "The DNA sequence, annotation and analysis of human chromosome 3.";
RL   Nature 440:1194-1198(2006).
RN   [3]
RP   TISSUE SPECIFICITY.
RX   PubMed=14726470; DOI=10.1373/clinchem.2003.026849;
RA   Hafner C., Schmitz G., Meyer S., Bataille F., Hau P., Langmann T.,
RA   Dietmaier W., Landthaler M., Vogt T.;
RT   "Differential gene expression of Eph receptors and ephrins in benign human
RT   tissues and cancers.";
RL   Clin. Chem. 50:490-499(2004).
RN   [4]
RP   VARIANT [LARGE SCALE ANALYSIS] SER-704.
RX   PubMed=17344846; DOI=10.1038/nature05610;
RA   Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C., Bignell G.,
RA   Davies H., Teague J., Butler A., Stevens C., Edkins S., O'Meara S.,
RA   Vastrik I., Schmidt E.E., Avis T., Barthorpe S., Bhamra G., Buck G.,
RA   Choudhury B., Clements J., Cole J., Dicks E., Forbes S., Gray K.,
RA   Halliday K., Harrison R., Hills K., Hinton J., Jenkinson A., Jones D.,
RA   Menzies A., Mironenko T., Perry J., Raine K., Richardson D., Shepherd R.,
RA   Small A., Tofts C., Varian J., Webb T., West S., Widaa S., Yates A.,
RA   Cahill D.P., Louis D.N., Goldstraw P., Nicholson A.G., Brasseur F.,
RA   Looijenga L., Weber B.L., Chiew Y.-E., DeFazio A., Greaves M.F.,
RA   Green A.R., Campbell P., Birney E., Easton D.F., Chenevix-Trench G.,
RA   Tan M.-H., Khoo S.K., Teh B.T., Yuen S.T., Leung S.Y., Wooster R.,
RA   Futreal P.A., Stratton M.R.;
RT   "Patterns of somatic mutation in human cancer genomes.";
RL   Nature 446:153-158(2007).
CC   -!- FUNCTION: Receptor tyrosine kinase which binds promiscuously GPI-
CC       anchored ephrin-A family ligands residing on adjacent cells, leading to
CC       contact-dependent bidirectional signaling into neighboring cells. The
CC       signaling pathway downstream of the receptor is referred to as forward
CC       signaling while the signaling pathway downstream of the ephrin ligand
CC       is referred to as reverse signaling (By similarity). {ECO:0000250}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + L-tyrosyl-[protein] = ADP + H(+) + O-phospho-L-tyrosyl-
CC         [protein]; Xref=Rhea:RHEA:10596, Rhea:RHEA-COMP:10136, Rhea:RHEA-
CC         COMP:10137, ChEBI:CHEBI:15378, ChEBI:CHEBI:30616, ChEBI:CHEBI:46858,
CC         ChEBI:CHEBI:82620, ChEBI:CHEBI:456216; EC=2.7.10.1;
CC         Evidence={ECO:0000255|PROSITE-ProRule:PRU10028};
CC   -!- SUBUNIT: Heterotetramer upon binding of the ligand. The heterotetramer
CC       is composed of an ephrin dimer and a receptor dimer. Oligomerization is
CC       probably required to induce biological responses (By similarity).
CC       Interacts (via SAM domain) with ANKS1A (via SAM domain) (By
CC       similarity). {ECO:0000250, ECO:0000250|UniProtKB:Q62413}.
CC   -!- INTERACTION:
CC       Q9UF33; Q04771: ACVR1; NbExp=2; IntAct=EBI-3950019, EBI-1383616;
CC       Q9UF33; P29317: EPHA2; NbExp=3; IntAct=EBI-3950019, EBI-702104;
CC       Q9UF33; P54760: EPHB4; NbExp=2; IntAct=EBI-3950019, EBI-702121;
CC   -!- SUBCELLULAR LOCATION: Membrane {ECO:0000250}; Single-pass type I
CC       membrane protein {ECO:0000250}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1;
CC         IsoId=Q9UF33-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q9UF33-2; Sequence=VSP_018473, VSP_018474, VSP_018475,
CC                                  VSP_018476;
CC       Name=3;
CC         IsoId=Q9UF33-3; Sequence=VSP_018473, VSP_018474, VSP_054716,
CC                                  VSP_054717;
CC   -!- TISSUE SPECIFICITY: Expressed in brain and testis.
CC       {ECO:0000269|PubMed:14726470}.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. Tyr protein
CC       kinase family. Ephrin receptor subfamily. {ECO:0000255|PROSITE-
CC       ProRule:PRU00159}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AL133666; CAB63775.1; -; mRNA.
DR   EMBL; AC109782; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC108714; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC110717; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC134730; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC135369; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC119745; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC107482; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC117470; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC130510; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC117439; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   CCDS; CCDS54616.1; -. [Q9UF33-2]
DR   CCDS; CCDS63697.1; -. [Q9UF33-3]
DR   PIR; T43450; T43450.
DR   RefSeq; NP_001265229.1; NM_001278300.1. [Q9UF33-3]
DR   RefSeq; NP_775926.1; NM_173655.3. [Q9UF33-2]
DR   AlphaFoldDB; Q9UF33; -.
DR   SMR; Q9UF33; -.
DR   BioGRID; 130049; 11.
DR   IntAct; Q9UF33; 34.
DR   MINT; Q9UF33; -.
DR   STRING; 9606.ENSP00000374323; -.
DR   BindingDB; Q9UF33; -.
DR   ChEMBL; CHEMBL4526; -.
DR   DrugBank; DB12010; Fostamatinib.
DR   DrugCentral; Q9UF33; -.
DR   GlyGen; Q9UF33; 3 sites.
DR   iPTMnet; Q9UF33; -.
DR   PhosphoSitePlus; Q9UF33; -.
DR   BioMuta; EPHA6; -.
DR   DMDM; 97048747; -.
DR   jPOST; Q9UF33; -.
DR   MassIVE; Q9UF33; -.
DR   MaxQB; Q9UF33; -.
DR   PaxDb; Q9UF33; -.
DR   PeptideAtlas; Q9UF33; -.
DR   PRIDE; Q9UF33; -.
DR   ProteomicsDB; 13364; -.
DR   ProteomicsDB; 84168; -. [Q9UF33-1]
DR   ProteomicsDB; 84169; -. [Q9UF33-2]
DR   Antibodypedia; 32095; 409 antibodies from 34 providers.
DR   DNASU; 285220; -.
DR   Ensembl; ENST00000502694.1; ENSP00000423950.1; ENSG00000080224.18. [Q9UF33-2]
DR   Ensembl; ENST00000514100.5; ENSP00000421711.1; ENSG00000080224.18. [Q9UF33-3]
DR   GeneID; 285220; -.
DR   KEGG; hsa:285220; -.
DR   UCSC; uc003drr.6; human. [Q9UF33-1]
DR   CTD; 285220; -.
DR   DisGeNET; 285220; -.
DR   GeneCards; EPHA6; -.
DR   HGNC; HGNC:19296; EPHA6.
DR   HPA; ENSG00000080224; Group enriched (brain, ovary, testis).
DR   MIM; 600066; gene.
DR   neXtProt; NX_Q9UF33; -.
DR   OpenTargets; ENSG00000080224; -.
DR   PharmGKB; PA134866684; -.
DR   VEuPathDB; HostDB:ENSG00000080224; -.
DR   eggNOG; KOG0196; Eukaryota.
DR   GeneTree; ENSGT00940000154490; -.
DR   HOGENOM; CLU_000288_141_5_1; -.
DR   InParanoid; Q9UF33; -.
DR   OrthoDB; 933071at2759; -.
DR   PathwayCommons; Q9UF33; -.
DR   Reactome; R-HSA-2682334; EPH-Ephrin signaling.
DR   Reactome; R-HSA-3928663; EPHA-mediated growth cone collapse.
DR   Reactome; R-HSA-3928665; EPH-ephrin mediated repulsion of cells.
DR   SignaLink; Q9UF33; -.
DR   SIGNOR; Q9UF33; -.
DR   BioGRID-ORCS; 285220; 7 hits in 1100 CRISPR screens.
DR   ChiTaRS; EPHA6; human.
DR   GeneWiki; EPHA6; -.
DR   GenomeRNAi; 285220; -.
DR   Pharos; Q9UF33; Tchem.
DR   PRO; PR:Q9UF33; -.
DR   Proteomes; UP000005640; Chromosome 3.
DR   RNAct; Q9UF33; protein.
DR   Bgee; ENSG00000080224; Expressed in left testis and 89 other tissues.
DR   ExpressionAtlas; Q9UF33; baseline and differential.
DR   Genevisible; Q9UF33; HS.
DR   GO; GO:0005887; C:integral component of plasma membrane; IBA:GO_Central.
DR   GO; GO:0043005; C:neuron projection; IBA:GO_Central.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0005886; C:plasma membrane; TAS:Reactome.
DR   GO; GO:0043235; C:receptor complex; IBA:GO_Central.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0004714; F:transmembrane receptor protein tyrosine kinase activity; IBA:GO_Central.
DR   GO; GO:0005005; F:transmembrane-ephrin receptor activity; IBA:GO_Central.
DR   GO; GO:0007411; P:axon guidance; IBA:GO_Central.
DR   GO; GO:0033674; P:positive regulation of kinase activity; IBA:GO_Central.
DR   GO; GO:0007169; P:transmembrane receptor protein tyrosine kinase signaling pathway; IBA:GO_Central.
DR   CDD; cd10484; EphR_LBD_A6; 1.
DR   CDD; cd00063; FN3; 2.
DR   CDD; cd09547; SAM_EPH-A6; 1.
DR   Gene3D; 1.10.150.50; -; 1.
DR   Gene3D; 2.60.40.10; -; 2.
DR   InterPro; IPR042746; EPH-A6_SAM.
DR   InterPro; IPR027936; Eph_TM.
DR   InterPro; IPR034280; EphA6_rcpt_lig-bd.
DR   InterPro; IPR001090; Ephrin_rcpt_lig-bd_dom.
DR   InterPro; IPR003961; FN3_dom.
DR   InterPro; IPR036116; FN3_sf.
DR   InterPro; IPR008979; Galactose-bd-like_sf.
DR   InterPro; IPR009030; Growth_fac_rcpt_cys_sf.
DR   InterPro; IPR013783; Ig-like_fold.
DR   InterPro; IPR011009; Kinase-like_dom_sf.
DR   InterPro; IPR000719; Prot_kinase_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   InterPro; IPR001660; SAM.
DR   InterPro; IPR013761; SAM/pointed_sf.
DR   InterPro; IPR001245; Ser-Thr/Tyr_kinase_cat_dom.
DR   InterPro; IPR011641; Tyr-kin_ephrin_A/B_rcpt-like.
DR   InterPro; IPR008266; Tyr_kinase_AS.
DR   InterPro; IPR020635; Tyr_kinase_cat_dom.
DR   InterPro; IPR016257; Tyr_kinase_ephrin_rcpt.
DR   InterPro; IPR001426; Tyr_kinase_rcpt_V_CS.
DR   Pfam; PF14575; EphA2_TM; 1.
DR   Pfam; PF01404; Ephrin_lbd; 1.
DR   Pfam; PF07699; Ephrin_rec_like; 1.
DR   Pfam; PF00041; fn3; 2.
DR   Pfam; PF07714; PK_Tyr_Ser-Thr; 2.
DR   Pfam; PF00536; SAM_1; 1.
DR   PIRSF; PIRSF000666; TyrPK_ephrin_receptor; 1.
DR   PRINTS; PR00109; TYRKINASE.
DR   SMART; SM00615; EPH_lbd; 1.
DR   SMART; SM00060; FN3; 2.
DR   SMART; SM00454; SAM; 1.
DR   SMART; SM00219; TyrKc; 1.
DR   SUPFAM; SSF47769; SSF47769; 1.
DR   SUPFAM; SSF49265; SSF49265; 1.
DR   SUPFAM; SSF49785; SSF49785; 1.
DR   SUPFAM; SSF56112; SSF56112; 1.
DR   SUPFAM; SSF57184; SSF57184; 1.
DR   PROSITE; PS51550; EPH_LBD; 1.
DR   PROSITE; PS50853; FN3; 2.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00109; PROTEIN_KINASE_TYR; 1.
DR   PROSITE; PS00790; RECEPTOR_TYR_KIN_V_1; 1.
DR   PROSITE; PS00791; RECEPTOR_TYR_KIN_V_2; 1.
DR   PROSITE; PS50105; SAM_DOMAIN; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; ATP-binding; Glycoprotein; Kinase; Membrane;
KW   Nucleotide-binding; Phosphoprotein; Receptor; Reference proteome; Repeat;
KW   Signal; Transferase; Transmembrane; Transmembrane helix;
KW   Tyrosine-protein kinase.
FT   SIGNAL          1..22
FT                   /evidence="ECO:0000255"
FT   CHAIN           23..1036
FT                   /note="Ephrin type-A receptor 6"
FT                   /id="PRO_0000235684"
FT   TOPO_DOM        23..550
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        551..571
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        572..1036
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   DOMAIN          34..212
FT                   /note="Eph LBD"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00883"
FT   DOMAIN          331..441
FT                   /note="Fibronectin type-III 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00316"
FT   DOMAIN          442..537
FT                   /note="Fibronectin type-III 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00316"
FT   DOMAIN          631..944
FT                   /note="Protein kinase"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   DOMAIN          961..1025
FT                   /note="SAM"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00184"
FT   MOTIF           1034..1036
FT                   /note="PDZ-binding"
FT                   /evidence="ECO:0000255"
FT   ACT_SITE        798
FT                   /note="Proton acceptor"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159,
FT                   ECO:0000255|PROSITE-ProRule:PRU10028"
FT   BINDING         637..645
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   BINDING         663
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   MOD_RES         606
FT                   /note="Phosphotyrosine; by autocatalysis"
FT                   /evidence="ECO:0000255"
FT   MOD_RES         612
FT                   /note="Phosphotyrosine; by autocatalysis"
FT                   /evidence="ECO:0000255"
FT   MOD_RES         831
FT                   /note="Phosphotyrosine; by autocatalysis"
FT                   /evidence="ECO:0000255"
FT   MOD_RES         978
FT                   /note="Phosphotyrosine; by autocatalysis"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        343
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        397
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        410
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   VAR_SEQ         1..514
FT                   /note="Missing (in isoform 2 and isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:17974005"
FT                   /id="VSP_018473"
FT   VAR_SEQ         515..538
FT                   /note="IRVRTATGYSGYSQKFEFETGDET -> MKDSPFQVTKLYWLNEKWDFIASA
FT                   (in isoform 2 and isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:17974005"
FT                   /id="VSP_018474"
FT   VAR_SEQ         835..912
FT                   /note="GGKIPIRWTAPEAIAYRKFSSASDAWSYGIVMWEVMSYGERPYWEMSNQDVI
FT                   LSIEEGYRLPAPMGCPASLHQLMLHC -> RPTNHNKEQSELVKEDGLESLCEQCESSS
FT                   GYGTGLVLMWKRNRRAMGASGQTRKQCDKRDNPPTDLFQTLTLNLCYSA (in
FT                   isoform 3)"
FT                   /evidence="ECO:0000305"
FT                   /id="VSP_054716"
FT   VAR_SEQ         835..848
FT                   /note="GGKIPIRWTAPEAI -> DLFQTLTLNLCYSA (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:17974005"
FT                   /id="VSP_018475"
FT   VAR_SEQ         849..1036
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:17974005"
FT                   /id="VSP_018476"
FT   VAR_SEQ         913..1036
FT                   /note="Missing (in isoform 3)"
FT                   /evidence="ECO:0000305"
FT                   /id="VSP_054717"
FT   VARIANT         704
FT                   /note="F -> S"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_042149"
FT   VARIANT         711
FT                   /note="A -> V (in dbSNP:rs4857276)"
FT                   /id="VAR_055991"
SQ   SEQUENCE   1036 AA;  116379 MW;  53402C6DCD7CD32C CRC64;
     MGGCEVREFL LQFGFFLPLL TAWPGDCSHV SNNQVVLLDT TTVLGELGWK TYPLNGWDAI
     TEMDEHNRPI HTYQVCNVME PNQNNWLRTN WISRDAAQKI YVEMKFTLRD CNSIPWVLGT
     CKETFNLFYM ESDESHGIKF KPNQYTKIDT IAADESFTQM DLGDRILKLN TEIREVGPIE
     RKGFYLAFQD IGACIALVSV RVFYKKCPFT VRNLAMFPDT IPRVDSSSLV EVRGSCVKSA
     EERDTPKLYC GADGDWLVPL GRCICSTGYE EIEGSCHACR PGFYKAFAGN TKCSKCPPHS
     LTYMEATSVC QCEKGYFRAE KDPPSMACTR PPSAPRNVVF NINETALILE WSPPSDTGGR
     KDLTYSVICK KCGLDTSQCE DCGGGLRFIP RHTGLINNSV IVLDFVSHVN YTFEIEAMNG
     VSELSFSPKP FTAITVTTDQ DAPSLIGVVR KDWASQNSIA LSWQAPAFSN GAILDYEIKY
     YEKEHEQLTY SSTRSKAPSV IITGLKPATK YVFHIRVRTA TGYSGYSQKF EFETGDETSD
     MAAEQGQILV IATAAVGGFT LLVILTLFFL ITGRCQWYIK AKMKSEEKRR NHLQNGHLRF
     PGIKTYIDPD TYEDPSLAVH EFAKEIDPSR IRIERVIGAG EFGEVCSGRL KTPGKREIPV
     AIKTLKGGHM DRQRRDFLRE ASIMGQFDHP NIIRLEGVVT KRSFPAIGVE AFCPSFLRAG
     FLNSIQAPHP VPGGGSLPPR IPAGRPVMIV VEYMENGSLD SFLRKHDGHF TVIQLVGMLR
     GIASGMKYLS DMGYVHRDLA ARNILVNSNL VCKVSDFGLS RVLEDDPEAA YTTTGGKIPI
     RWTAPEAIAY RKFSSASDAW SYGIVMWEVM SYGERPYWEM SNQDVILSIE EGYRLPAPMG
     CPASLHQLML HCWQKERNHR PKFTDIVSFL DKLIRNPSAL HTLVEDILVM PESPGEVPEY
     PLFVTVGDWL DSIKMGQYKN NFVAAGFTTF DLISRMSIDD IRRIGVILIG HQRRIVSSIQ
     TLRLHMMHIQ EKGFHV
//
